CBD is a medication used to manage and treat the seizure disorders Lennox-Gastaut syndrome and Dravet syndrome. This activity describes the indications, action, and contraindications for CBD as a valuable agent in the treatment and management of Lennox-Gastaut syndrome and Dravet syndrome and also highlights the mechanism of action, adverse event profile, and other key factors such as current research trials ongoing for CBD use.

**Objectives:**
- Review the current and future indications for CBD.
- Explain the importance of monitoring patients on CBD.
- Summarize the contraindications and factors to consider when prescribing CBD.
- Describe the importance of collaboration and communication amongst the interprofessional team to improve outcomes for patients receiving CBD.